US Patent 7960129 Assays and methods for determining STIM2 activity
Patent 7960129 was granted and assigned to The Queen's Medical Center on June, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+213 characters)
Article
Patent abstract
The present invention provides assays and methods for determining levels of STIM2 activity, thus providing tools for the characterization and study of the regulation of intracellular calcium levels.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07960129 Assays and methods for determining STIM2 activity US Patent 7960129 Assays and methods for determining STIM2 activity
Infobox
Patent Number
0796012900
Patent Number
796012900
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079601290
Date of Patent
June 14, 2011
0Patent Application Number
120533290
Date Filed
March 21, 2008
0Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079601290
Date of Patent
June 14, 2011
0Patent Application Number
120533290
Date Filed
March 21, 2008
0Patent Primary Examiner
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07960129 Assays and methods for determining STIM2 activity
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07960129
Date of patent
June 14, 2011
Patent application number
12053329
Date Filed
March 21, 2008
Patent primary examiner
Find more entities like US Patent 7960129 Assays and methods for determining STIM2 activity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
